Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells

Triple-negative breast cancer (TNBC) is among the most aggressive breast cancer subtypes. Despite being initially responsive to chemotherapy, patients develop drug-resistant and metastatic tumors. Tissue inhibitor of metalloproteinases-1 (TIMP-1) is a secreted protein with a tumor suppressor functio...

Full description

Bibliographic Details
Main Authors:	Lisa Agnello, Annachiara d’Argenio, Alessandra Caliendo, Roberto Nilo, Antonella Zannetti, Monica Fedele, Simona Camorani, Laura Cerchia
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Cells
Subjects:	chemoresistance triple-negative breast cancer tumor microenvironment tissue inhibitor of metalloproteinases-1 CD63 cell receptor
Online Access:	https://www.mdpi.com/2073-4409/12/13/1809

Similar Items

TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities
by: Simona Camorani, et al.
Published: (2018-11-01)

Optimization of Short RNA Aptamers for TNBC Cell Targeting
by: Simona Camorani, et al.
Published: (2022-03-01)

Aptamer-Based Strategies to Boost Immunotherapy in TNBC
by: Lisa Agnello, et al.
Published: (2023-03-01)

Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells
by: Simona Camorani, et al.
Published: (2022-10-01)

Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors
by: Lisa Agnello, et al.
Published: (2021-07-01)

The Oxygen-Generating Calcium Peroxide-Modified Magnetic Nanoparticles Attenuate Hypoxia-Induced Chemoresistance in Triple-Negative Breast Cancer
by: Fong-Yu Cheng, et al.
Published: (2021-02-01)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
by: Meng Wang, et al.
Published: (2021-10-01)

Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells
by: Annachiara Sarnella, et al.
Published: (2023-01-01)

Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death
by: Jean-Pierre Delord, et al.
Published: (2012-07-01)

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1
by: Wentao Si, et al.
Published: (2022-11-01)

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
by: Liu C, et al.
Published: (2020-12-01)

Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer
by: Simona Camorani, et al.
Published: (2020-09-01)

Reconstructing Tumor Microenvironment Using Photoresponsive Cyanobacteria to Reversal Chemoresistance for Robust Chemotherapy
by: Huamei He, et al.
Published: (2023-05-01)

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer
by: Alaa M. Ghallab, et al.
Published: (2022-04-01)

Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk
by: Hongquan Qin, et al.
Published: (2023-10-01)

Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
by: Shen-Jun Yuan, et al.
Published: (2019-10-01)

TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway
by: Weiguang Liu, et al.
Published: (2019-09-01)

Impact of Obesity and Lysosomal Dysfunction on Chemoresistance in Ovarian Cancer
by: Boyun Kim, et al.
Published: (2024-03-01)

Microglia-mediated drug substance transfer promotes chemoresistance in brain tumors: insights from an in vitro co-culture model using GCV/Tk prodrug system
by: Sheng-Yan Wu, et al.
Published: (2024-01-01)

The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
by: Lin He, et al.
Published: (2021-12-01)

Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines
by: Ammar Said Suliman, et al.
Published: (2021-01-01)

USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
by: Yueh-Te Lin, et al.
Published: (2022-10-01)

M6A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer
by: Xi Liu, et al.
Published: (2024-02-01)

TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway
by: Weiguang Liu, et al.
Published: (2019-07-01)

Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance
by: Lucy V. Ireland, et al.
Published: (2018-10-01)

TIMP-1-Mediated Chemoresistance via Induction of IL-6 in NSCLC
by: Wei Xiao, et al.
Published: (2019-08-01)

Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
by: Lei Yu, et al.
Published: (2022-10-01)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
by: Ling Wang, et al.
Published: (2018-07-01)

Comparative Analysis of P63, Maspin and Matrix Metalloproteinase 2 Expression in Mucoepidermoid Carcinoma and Adenoid Cystic Carcinoma of Salivary Glands
by: Nasim Taghavi, et al.
Published: (2020-06-01)

Cytokines, breast cancer stem cells (BCSCs) and chemoresistance
by: Weilong Chen, et al.
Published: (2018-09-01)

Extracellular Vesicles and the Inflammasome: An Intricate Network Sustaining Chemoresistance
by: Letizia Mezzasoma, et al.
Published: (2022-04-01)

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
by: Bradley A. Hancock, et al.
Published: (2019-08-01)

New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment
by: Agnès eNoël
Published: (2012-07-01)

Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells
by: Yifat Koren Carmi, et al.
Published: (2024-06-01)

A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
by: Hitesh Kumar, et al.
Published: (2023-12-01)

Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer
by: Junliang Chen, et al.
Published: (2023-05-01)

Tumor-initiating CD49f cells are a hallmark of chemoresistant triple negative breast cancer
by: Jorge Gomez-Miragaya, et al.
Published: (2017-07-01)

The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer
by: Chang Liu, et al.
Published: (2021-09-01)

Early Mechanisms of Chemoresistance in Retinoblastoma
by: Michelle G. Zhang, et al.
Published: (2022-10-01)

Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
by: Xun Chen, et al.
Published: (2020-07-01)